McCollum Christoferson Group’s Pfizer PFE Stock Holding History

McCollum Christoferson Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,229	Closed	-$217K	–	75
2020 Q3	$217K	Buy	+6,229	New	+$218K	0.06%	71
2020 Q1	–	Sell	-5,431	Closed	-$202K	–	67
2019 Q4	$202K	Sell	5,431 -2,424	-31%	-$86.3K	0.07%	70
2019 Q3	$268K	Hold	7,855	–	–	0.1%	60
2019 Q2	$323K	Hold	7,855	–	–	0.11%	59
2019 Q1	$317K	Buy	+7,855	New	+$315K	0.12%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

McCollum Christoferson Group's PFE Position: Q4 2020 in Review

McCollum Christoferson Group sold out of Pfizer (PFE) in Q4 2020, closing a stake of 6,229 shares — an estimated $217K sold.

McCollum Christoferson Group first reported a position in PFE in Q1 2019 and held it in 5 quarters. The position peaked at $323K in Q2 2019. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

McCollum Christoferson Group reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
McCollum Christoferson Group sold 6,229 Pfizer shares in Q4 2020, an estimated $217K.
McCollum Christoferson Group first reported a position in Pfizer in Q1 2019 and held it in 5 quarters.
McCollum Christoferson Group's Pfizer position peaked at $323K in Q2 2019.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on McCollum Christoferson Group's 13F filing for Q4 2020, filed 22 Jan 2021.